Company / Working Capital
Ginkgo Bioworks Holdings, Inc. Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$375.9M
FY2025
5-year range
$375.9M / $1.6B
FY2021-FY2025
Trend
-24.1%
vs FY2024
Sector context
#120 of 215
Health Care
What the data says
At $376M, Ginkgo Bioworks Holdings, Inc.'s working capital ranks #120 of 215 in the Health Care sector. Working Capital has declined for 4 consecutive years, from $1.6B in FY2021 to $376M in FY2025.
Based on SEC 10-K filings.
$376M in FY2025 with a 5-year CAGR of +1.2%.
Declined from $838M to $376M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -33.5%
- 5-Year CAGR
- +1.2%
- 10-Year CAGR
- -
Sector benchmark
#120 of 215 in Health CareTop 56% of 215This company $375.9M Sector average $957.8M
▼
-60.8% below sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s working capital has declined for 4 consecutive years.
- 5-year CAGR of +1.2%, indicating consistent growth.
- In FY2025, working capital decreased 24.1% year-over-year.
- Ranks #120 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $375.9M | -24.1% |
| FY2024 | $495.5M | -40.9% |
| FY2023 | $837.9M | -34.4% |
| FY2022 | $1.3B | -19.6% |
| FY2021 | $1.6B | +349.5% |
| FY2020 | $353.3M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026